Dynamics of Viral and Host 3D Genome Structure upon Infection

키워드

참고문헌 (107)

1. Benabdallah NS, "Decreased enhancer-promoter proximity accompanying enhancer activation", Mol. Cell, 76, pp.473~484 (2019)[DOI]
2. Zheng H, "The role of 3D genome organization in development and cell differentiation", Nat. Rev. Mol. Cell Biol, 20, pp.535~550 (2019)
3. Kubo N, "Promoter-proximal CTCF binding promotes distal enhancerdependent gene activation", Nat. Struct. Mol. Biol, 28, pp.152~161 (2021)
4. Oh S, "Enhancer release and retargeting activates disease-susceptibility genes", Nature, 595, pp.735~740 (2021)
5. Simonis M, "Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip(4C)", Nat. Genet, 38, pp.1348~1354 (2006)
6. Dostie J, "Chromosome conformation capture carbon copy(5C) : a massively parallel solution for mapping interactions between genomic elements", Genome Res, 16, pp.1299~1309 (2006)
7. Jäger R, "Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci", Nat. Commun, 6, pp.6178~ (2015)
8. Fang R, "Mapping of long-range chromatin interactions by proximity ligationassisted ChIP-seq", Cell Res, 26, pp.1345~1348 (2016)
9. Fullwood MJ, "Next-generation DNA sequencing of paired-end tags(PET)for transcriptome and genome analyses", Genome Res, 19, pp.521~532 (2009)
10. Sati S, "Chromosome conformation capture technologies and their impact in understanding genome function", Chromosoma, 126, pp.33~44 (2017)
11. Hsieh TH, "Mapping nucleosome resolution chromosome folding in yeast by micro-C", Cell, 162, pp.108~119 (2015)
12. Quinodoz SA, "SPRITE : a genome-wide method for mapping higher-order 3D interactions in the nucleus using combinatorial split-and-pool barcoding", Nat. Protoc, 17, pp.36~75 (2022)
13. Beagrie RA, "Complex multi-enhancer contacts captured by genome architecture mapping", Nature, 543, pp.519~524 (2017)
14. Consortium IH, "The international HapMap project", Nature, 426, pp.789~796 (2003)
15. Consortium EP, "An integrated encyclopedia of DNA elements in the human genome", Nature, 489, pp.57~74 (2021)
16. Arvey A, "An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions", Cell Host Microbe, 12, pp.233~245 (2012)
17. Rao SS, "A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping", Cell, 159, pp.1665~1680 (2014)
18. Quinodoz SA, "Higher-order inter-chromosomal hubs shape 3D genome organization in the nucleus", Cell, 174, pp.744~757 (2018)[DOI]
19. Buschle A, "Epigenetic lifestyle of Epstein-Barr virus", Semin Immunopathol, 42, pp.131~142 (2020)
20. Toth Z, "The chromatin landscape of Kaposi's sarcoma-associated herpesvirus", Viruses, 5, pp.1346~1373 (2013)
21. Chen HS, "Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency", J. Virol, 8, pp.9454~9464 (2012)
22. Zhao B, "Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth", Proc. Natl. Acad. Sci. USA, 108, pp.14902~14907 (2011)
23. Chau CM, "Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF", J. Virol, 80, pp.5723~5732 (2006)
24. Hughes DJ, "Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency", J. Virol, 86, pp.1034~1045 (2012)
25. Tempera I, "CTCF prevents the epigenetic drift of EBV latency promoter Qp", PLoS Pathog, 6, pp.e1001048~ (2010)
26. Chen HS, "Epigenetic deregulation of the LMP1", LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site, 2014, pp.88, 1703~1713
27. Molyneux EM, "Burkitt's lymphoma", Lancet, 379, pp.1234~1244 (2012)
28. Wang LW, "Epstein-Barr-v-induced one-carbon metabolism drives B cell transformation", Cell Metab, 30, pp.539~555 (2019)
29. Wood CD, "MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs", Elife, 5, pp.e18270~ (2016)
30. Jiang S, "The Epstein-Barr virus regulome in lymphoblastoid cells", Cell Host Microbe, 22, pp.561~573 (2017)[DOI]
31. Guo R, "MYC controls the epstein-barr virus lytic switch", Mol. Cell, 78, pp.653~669 (2020)[DOI]
32. Knipe DM, "Snapshots : chromatin control of viral infection", Virology, 435, pp.141~156 (2013)
33. zStedman W, "Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19", Igf2 insulators, 2008, pp.27, 654~666
34. Li DJ, "CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcomaassociated herpesvirus(KSHV)lytic replication by modulating viral gene transcription", PLoS Pathog, 10, pp.e1003880~ (2014)
35. Park A, "Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs", Proc. Natl. Acad. Sci. USA, 117, pp.21618~21627 (2020)
36. Bloom DC, "Epigenetic regulation of latent HSV-1 gene expression", Biochim. Biophys. Acta, 1799, pp.246~256 (2010)
37. Ertel MK, "CTCF occupation of the herpes simplex virus 1 genome is disrupted at early times postreactivation in a transcription-dependent manner", J. Virol, 86, pp.12741~12759 (2012)
38. Martínez FP, "CTCF binding to the first intron of the major immediate early(MIE)gene of human cytomegalovirus(HCMV)negatively regulates MIE gene expression and HCMV replication", J. Virol, 88, pp.7389~7401 (2014)
39. Lee JS, "CCCTC-binding factor acts as a heterochromatin barrier on herpes simplex viral latent chromatin and contributes to poised latent infection", mBio, 9, pp.e02372~17 (2018)
40. Lang F, "CTCF interacts with the lytic HSV-1 genome to promote viral transcription", Sci. Rep, 7, pp.39861~ (2017)
41. Li X, "Cohesin promotes HSV-1 lytic transcription by facilitating the binding of RNA Pol II on viral genes", Virol. J, 18, pp.26~ (2021)
42. Morgan SM, "The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity", Nat. Commun, 13, pp.187~ (2022)
43. Campbell M, "KSHV episomes reveal dynamic chromatin loop formation with domain-specific gene regulation", Nat. Commun, 9, pp.49~ (2018)
44. Campbell M, "KSHV topologically associating domains in latent and reactivated viral chromatin", J. Virol, 96, pp.e0056522~ (2022)
45. Moquin SA, "The epstein-barr virus episome maneuvers between nuclear chromatin compartments during reactivation", J. Virol, 92, pp.e01413~17 (2018)
46. Kim, "Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus", Nat. Commun, 11, pp.877~ (2020)
47. Okabe A, "Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma", Nat. Genet, 52, pp.919~930 (2020)
48. Caruso LB, "The nuclear lamina binds the EBV genome during latency and regulates viral gene expression", PLoS Pathog, 18, pp.e1010400~ (2022)
49. Luopin Wang, "Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells", Journal of Virology, 94(24) (2020), American Society for Microbiology[DOI]
50. Kumar A, "KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4", Cell Rep, 39, pp.110788~ (2022)
51. Ballestas ME, "The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcomaassociated herpesvirus latency", Future Microbiol, 6, pp.1399~1413 (2011)
52. Walboomers JM, "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", J. Pathol, 189, pp.12~19 (1999)
53. McLaughlin-Drubin ME, "Oncogenic activities of human papillomaviruses", Virus Res, 143, pp.195~208 (2009)
54. Cao C, "HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer", J. Genet. Genomics, 47, pp.437~450 (2020)
55. Zhou, C., "Papillomavirus immune evasion strategies target the infected cell and the local immune system", Front. Oncol, 9, pp.682~ (2019)
56. Mehta K, "Human papillomaviruses activate and recruit SMC1 cohesin proteins for the differentiation-dependent life cycle through association with CTCF insulators", PLoS Pathog, 11, pp.e1004763~ (2015)
57. Mehta K, "Human papillomaviruses preferentially recruit DNA repair factors to viral genomes for rapid repair and amplification", mBio, 9, pp.e00064~18 (2018)
58. Paris C, "CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression", J. Virol, 89, pp.4770~4785 (2015)
59. Pentland I, "Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription", PLoS Biol, 16, pp.e2005752~ (2018)
60. Ferguson J, "The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression", PLoS Pathog, 17, pp.e1010032~ (2021)
61. McBride AA, "The role of integration in oncogenic progression of HPV-associated cancers", PLoS Pathog, 13, pp.e1006211~ (2017)
62. Ojesina AI, "Landscape of genomic alterations in cervical carcinomas", Nature, 506, pp.371~375 (2014)
63. Dixon JR, "Integrative detection and analysis of structural variation in cancer genomes", Nat. Genet, 50, pp.1388~1398 (2018)
64. Shen C, "Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells", Int. J. Cancer, 141, pp.540~548 (2017)
65. Bodelon C, "Genomic characterization of viral integration sites in HPV-related cancers", Int. J. Cancer, 139, pp.2001~2011 (2016)
66. Kelley DZ, "Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks", Cancer Res, 77, pp.6538~6550 (2017)
67. Hu Z, "Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism", Nat. Genet, 47, pp.158~163 (2015)
68. Warburton A, "Recurrent integration of human papillomavirus genomes at transcriptional regulatory hubs", NPJ Genom. Med, 6, pp.101~ (2021)
69. Warburton A, "HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression", PLoS Genet, 14, pp.e1007179~ (2018)
70. Zhou L, "Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer", Nat. Commun, 13, pp.2563~ (2022)
71. Turner KM, "Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity", Nature, 543, pp.122~125 (2017)
72. Adeel MM, "Structural variations of the 3D genome architecture in cervical cancer development", Front. Cell Dev. Biol, 9, pp.706375~ (2021)
73. Mehran Karimzadeh, "Human papillomavirus integration transforms chromatin to drive oncogenesis" (2022)[DOI]
74. Lusic M, "Nuclear landscape of HIV-1 infection and integration", Nat. Rev. Microbiol, 15, pp.69~82 (2017)
75. Marini B, "Nuclear architecture dictates HIV-1 integration site selection", Nature, 521, pp.227~231 (2015)
76. Chen H-C, "Position effects influence HIV latency reversal", Nat. Struct. Mol. Biol, 24, pp.47~54 (2017)
77. Vansant G, "The chromatin landscape at the HIV-1 provirus integration site determines viral expression", Nucleic Acids Res, 48, pp.7801~7817 (2020)
78. Perkins KJ, "Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals", Mol. Cell, 29, pp.56~68 (2008)
79. Dieudonné M, "Transcriptional competence of the integrated HIV-1 provirus at the nuclear periphery", EMBO J, 28, pp.2231~2243 (2009)
80. Lucic B, "Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration", Nat. Commun, 10, pp.4059~ (2019)
81. "Genomic profiling of HIV-1 integration in microglia links viral insertions to TAD organization" (2022)[URL]
82. "An integrated genomics approach towards deciphering human genome codes shaping HIV-1 proviral transcription and fate" (2020)[URL]
83. Heinz S, "Transcription elongation can affect genome 3D structure", Cell, 174, pp.1522~1536 (2018)[DOI]
84. Shiimori M, "Suv4-20h2 protects against influenza virus infection by suppression of chromatin loop formation", iScience, 24, pp.102660~ (2021)
85. Shiimori M, "Dynamics of the host chromatin three-dimensional response to influenza virus infection", Int. Immunol, 33, pp.541~545 (2021)
86. Chen T, "A low-producing haplotype of interleukin-6 disrupting CTCF binding is protective against severe COVID-19", mBio, 12, pp.e0137221~ (2021)
87. Nakanishi T, "Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality", J. Clin. Invest, 131, pp.e152386~ (2021)
88. Stikker BS, "Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages", Genome Biol, 23, pp.96~ (2022)
89. Merad M, "Pathological inflammation in patients with COVID-19 : a key role for monocytes and macrophages", Nat. Rev. Immunol, 20, pp.355~362 (2020)
90. Szabo PA, "Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19", Immunity, 54, pp.797~814 (2021)[DOI]
91. Salgado-Albarrán M, "Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection", NPJ Syst. Biol. Appl, 7, pp.21~ (2021)
92. Huoman J, "Epigenome-wide DNA methylation profiling of healthy COVID-19 recoverees reveals a unique signature in circulating immune cells", MedRXiv (2021)[DOI]
94. Merkenschlager M, "CTCF and cohesin in genome folding and transcriptional gene regulation", Annu. Rev. Genomics Hum. Genet, 17, pp.17~43 (2016)
95. Yuen, "Taking cohesin and condensin in context", PLoS Genet, pp.14~ (2018)
96. Bjornevik K, "Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis", Science, 375, pp.296~301 (2022)
97. Itzhaki RF, "Does antiherpetic antiviral therapy reduce the risk of dementia?", Nat. Rev. Neurol, 18, pp.63~64 (2022)
98. Young-Xu Y, "Symptomatic herpes simplex virus infection and risk of dementia in US veterans : a cohort study", Neurotherapeutics, 18, pp.2458~2467 (2021)
99. Ma H, "Multicolor CRISPR labeling of chromosomal loci in human cells", Proc. Natl. Acad. Sci. USA, 112, pp.3002~3007 (2015)
100. Chen B, "Dynamic imaging of genomic loci in living human cells by an optimized CRISPR", Cas system, 2013, pp.155, 1479~1491
101. Washington SD, "Depletion of the insulator protein CTCF results in herpes simplex virus 1 reactivation", J. Virol, 92, pp.e00173~18 (2018)
102. Lupey-Green LN, "PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter", Virology, 507, pp.220~230 (2017)
103. Kang H, "Coordination of KSHV latent and lytic gene control by CTCFcohesin mediated chromosome conformation", PLoS Pathog, 7, pp.e1002140~ (2011)
104. Jefferys SR, "Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors", PLoS Pathog, 17, pp.e1009346~ (2021)
105. D'Arienzo V, "The CCCTC-binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription", Cell. Microbiol, 23, pp.e13274~ (2021)
106. Decorsière A, "Hepatitis B virus X protein identifies the Smc5", 6 complex as a host restriction factor, 2016, pp.531, 386~389
107. Komatsu T, "DNA replication-dependent binding of CTCF plays a critical role in adenovirus genome functions", Sci. Rep, 3, pp.2187~ (2013)